PDS Biotechnology Corp Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
PDS Biotechnology Corp (PDSB) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $1.71 million for the 3-month period ending 2022-12-31, per its 10-K filed 2024-03-28.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2024-03-28
- PDS Biotechnology Corp share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2022-12-31 was $1.71M.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month |
|---|---|
| 2022-12-31 | $1.71M 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |